Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology. Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing.
For more information, visit www.BrukerSpatialBiology.com
As always, Joe Beechem gets right to the point. What matters is 1. how many genes you can detect and 2. how many total transcripts you can discriminate per cell. The end. That outcome is ultimately limited by the detection chemistry. Fundamentally, CosMx chemistry is the smallest and the most scalable. Moreover, it only relies on two basic physical processes; hybridization and photocleavage. No complicated enzymology and bulky synthesis states. Whatever shortcomings there are now will resolve as CosMx technology continues to mature. Spatial Multiomics will advance according to the tool set available, so choose your tools rationally and objectively. As always, as a scientist.
The longest lasting vibrating material. Vibrantium? Super cool. Microchips when being able to sense sounds but also save it as data in video games. Like, isolation of different wavelengths.
NanoString Technologies Inc (NASDAQ:NSTG) shares are trading higher by 124.3% to $0.26 Friday afternoon after the company announced it secured a credit agreement with its existing lenders, consisting of $12.5 million in new term loans already approved for funding and an additional $35 million to be funded upon court approval. This totals $47.5 million, an increase from the initial commitment of $40 million. The financing aims to support the company through its restructuring process and sustain its ongoing operations, including product sales and development. What Would Donald Trump Do? Build Your Empire With Benzinga Love him or hate him: Donald Trump built a billion-dollar fortune by investing. Ready to join the ranks? Get unfiltered, no-nonsense, boots-on-the-ground political and stock market news every day with Benzinga. Want to grow your money in the smartest way possible? Join 200,000 others just like yourself right here. Meanwhile, NanoString’s CEO expressed gratitude to stakeholders and affirmed the company’s commitment to serving customers and the scientific community while exploring strategic options for long-term continuity. An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages - like NanoString Technologies‘s page for example - there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter. These are known as capital allocation programs. NanoString Technologies (NASDAQ:NSTG) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company. According to data from Benzinga Pro, NSTG has a 52-week high of $11.78 and a 52-week low of $0.05. What Would Donald Trump Do? Build Your Empire With Benzinga Love him or hate him: Donald Trump built a billion-dollar fortune by investing. Ready to join the ranks? Get unfiltered, no-nonsense, boots-on-the-ground political and stock market news every day with Benzinga. Want to grow your money in the smartest way possible? Join 200,000 others just like yourself right here. 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
How do you continue to work for a company that, from CEO to CSO have been found "acting in reckless disregard" of an existing patents by a jury? How do you justify the cost of litigation, the massive decline in share price, the black cloud hanging over all the scientists and engineers at NanoString? You worked there the entire time! The CSO is old and will just retire, the CEO will live on his Illumina stock. How will you justify your involvement for the next 20 yrs of your career?
NanoString keeps losing patent cases to 10X, this has been going on for far too long. The company needs to accept decisions and move on (perhaps even discontinue CosMx and GeoMx products) and not constantly legally challenge on a weak basis (Brad Gray needs to do a cost-benefit analysis), stop wasting money on endless court cases, that you can't win.
Great video and product! Quick question for anyone to chime in- does GeoMx get sequences from all cells of an ROI or subsets specified by user (or based on staining)? Thank you
Hi Jamie, I think you can do both. You can either collect the entire ROI, or you can use the “Segmentation” function to collect specific segments within an ROI. For example, you can collect the tumor region (defined by PanCK Staining) in segment 1 of the ROI, and the Stromal region within the same ROI in Segment 2. I hope this helps.
